Literature DB >> 23909735

Vitamin D transport proteins megalin and disabled-2 are expressed in prostate and colon epithelial cells and are induced and activated by all-trans-retinoic acid.

Shantel B Ternes1, Matthew J Rowling.   

Abstract

Megalin and disabled-2 (Dab2) are essential for uptake of the 25-hydroxycholecalciferol (25D3)-vitamin D binding protein (DBP) complex in tissues. In the kidney, this mechanism regulates serum 25D3 levels and production of 1,25-dihydroxycholecalciferol (1,25D3) by CYP27B1 for systemic use. Previously, we showed that mammary epithelial cells expressing CYP27B1 express megalin and Dab2 and internalize DBP by endocytosis, indicating 25D3 was accessible for conversion to 1,25D3 in extra-renal tissues. Moreover, induction of megalin and Dab2 (protein and mRNA abundance) by all-trans-retinoic acid (RA) enhanced DBP uptake. This suggests megalin and Dab2 play a central role in uptake of vitamin D and may predict actions of vitamin D in extra-renal tissues. Here, we characterized megalin and Dab2 expression and uptake of DBP in transformed human prostate and colon epithelial cells. Megalin and Dab2 were expressed in prostate and colon epithelial cells, which was markedly enhanced following treatment with RA. Furthermore, DBP uptake was stimulated by low-dose RA supplementation in LNCaP, PC-3, and Caco-2 cells. Taken together, these are the first studies to our knowledge that have demonstrated modulated expression of megalin and Dab2, as well as an association between increased expression of endocytic proteins with DBP uptake in prostate and colon cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23909735      PMCID: PMC4237279          DOI: 10.1080/01635581.2013.805422

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  54 in total

1.  Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

Authors:  Brian M Wolpin; Kimmie Ng; Ying Bao; Peter Kraft; Meir J Stampfer; Dominique S Michaud; Jing Ma; Julie E Buring; Howard D Sesso; I-Min Lee; Nader Rifai; Barbara B Cochrane; Jean Wactawski-Wende; Rowan T Chlebowski; Walter C Willett; JoAnn E Manson; Edward L Giovannucci; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-15       Impact factor: 4.254

2.  Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release.

Authors:  M Marinò; G Zheng; L Chiovato; A Pinchera; D Brown; D Andrews; R T McCluskey
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

Review 3.  What is the dose-response relationship between vitamin D and cancer risk?

Authors:  Cedric F Garland; William B Grant; Sharif B Mohr; Edward D Gorham; Frank C Garland
Journal:  Nutr Rev       Date:  2007-08       Impact factor: 7.110

4.  Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition.

Authors:  J Y Hsu; D Feldman; J E McNeal; D M Peehl
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

5.  An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3.

Authors:  A Nykjaer; D Dragun; D Walther; H Vorum; C Jacobsen; J Herz; F Melsen; E I Christensen; T E Willnow
Journal:  Cell       Date:  1999-02-19       Impact factor: 41.582

6.  Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China.

Authors:  Wanqing Chen; Mark Clements; Bayzidur Rahman; Siwei Zhang; Youlin Qiao; Bruce K Armstrong
Journal:  Cancer Causes Control       Date:  2010-06-16       Impact factor: 2.506

7.  Mutually dependent localization of megalin and Dab2 in the renal proximal tubule.

Authors:  J Nagai; E I Christensen; S M Morris; T E Willnow; J A Cooper; R Nielsen
Journal:  Am J Physiol Renal Physiol       Date:  2005-05-03

8.  Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis.

Authors:  Li Laine Ooi; Hong Zhou; Robert Kalak; Yu Zheng; Arthur D Conigrave; Markus J Seibel; Colin R Dunstan
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

9.  Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.

Authors:  Isabelle H Roland; Wan-Lin Yang; Dong-Hua Yang; Mary B Daly; Robert F Ozols; Thomas C Hamilton; Henry T Lynch; Andrew K Godwin; Xiang-Xi Xu
Journal:  Cancer       Date:  2003-12-15       Impact factor: 6.860

10.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.

Authors:  Joan M Lappe; Dianne Travers-Gustafson; K Michael Davies; Robert R Recker; Robert P Heaney
Journal:  Am J Clin Nutr       Date:  2007-06       Impact factor: 7.045

View more
  8 in total

1.  Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.

Authors:  Mingyang Song; Gauree Gupta Konijeti; Chen Yuan; Ashwin N Ananthakrishnan; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Kimmie Ng; Andrew T Chan
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-31

2.  Role of Renal Drug Exposure in Polymyxin B-Induced Nephrotoxicity.

Authors:  Pooja Manchandani; Jian Zhou; Jessica T Babic; Kimberly R Ledesma; Luan D Truong; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  Circulating 25-hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer.

Authors:  Chen Yuan; Irene M Shui; Kathryn M Wilson; Meir J Stampfer; Lorelei A Mucci; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

4.  Prostatic compensation of the vitamin D axis in African American men.

Authors:  Zachary Richards; Ken Batai; Rachael Farhat; Ebony Shah; Andrew Makowski; Peter H Gann; Rick Kittles; Larisa Nonn
Journal:  JCI Insight       Date:  2017-01-26

5.  Participation of the SMAD2/3 signalling pathway in the down regulation of megalin/LRP2 by transforming growth factor beta (TGF-ß1).

Authors:  Felipe Cabezas; Pamela Farfán; María-Paz Marzolo
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

6.  Vitamin D-Related Genes, Blood Vitamin D Levels and Colorectal Cancer Risk in Western European Populations.

Authors:  Veronika Fedirko; Hannah B Mandle; Wanzhe Zhu; David J Hughes; Afshan Siddiq; Pietro Ferrari; Isabelle Romieu; Elio Riboli; Bas Bueno-de-Mesquita; Fränzel J B van Duijnhoven; Peter D Siersema; Anne Tjønneland; Anja Olsen; Vittorio Perduca; Franck Carbonnel; Marie-Christine Boutron-Ruault; Tilman Kühn; Theron Johnson; Aleksandrova Krasimira; Antonia Trichopoulou; Periklis Makrythanasis; Dimitris Thanos; Salvatore Panico; Vittorio Krogh; Carlotta Sacerdote; Guri Skeie; Elisabete Weiderpass; Sandra Colorado-Yohar; Núria Sala; Aurelio Barricarte; Maria-Jose Sanchez; Ramón Quirós; Pilar Amiano; Björn Gylling; Sophia Harlid; Aurora Perez-Cornago; Alicia K Heath; Konstantinos K Tsilidis; Dagfinn Aune; Heinz Freisling; Neil Murphy; Marc J Gunter; Mazda Jenab
Journal:  Nutrients       Date:  2019-08-20       Impact factor: 6.706

7.  Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer.

Authors:  Chen Yuan; Mingyang Song; Yin Zhang; Brian M Wolpin; Jeffrey A Meyerhardt; Shuji Ogino; Bruce W Hollis; Andrew T Chan; Charles S Fuchs; Kana Wu; Molin Wang; Stephanie A Smith-Warner; Edward L Giovannucci; Kimmie Ng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-11       Impact factor: 4.254

8.  Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.

Authors:  Gabriella M Anic; Stephanie J Weinstein; Alison M Mondul; Satu Männistö; Demetrius Albanes
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.